Literature DB >> 18653182

Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.

Kenneth S Shindler1, Elvira Ventura, Mahasweta Dutt, Abdolmohamad Rostami.   

Abstract

Optic neuritis is an inflammatory disease of the optic nerve that often occurs in patients with multiple sclerosis and leads to permanent visual loss mediated by retinal ganglion cell (RGC) damage. Optic neuritis occurs with high frequency in relapsing-remitting experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, with significant loss of RGCs. In the current study, mechanisms of RGC loss in this model were examined to determine whether inflammation-induced axonal injury mediates apoptotic death of RGCs. RGCs were retrogradely labeled by injection of fluorogold into superior colliculi of 6-7 week old female SJL/J mice. EAE was induced one week later by immunization with proteolipid protein peptide. Optic neuritis was detected by inflammatory cell infiltration on histological examination as early as 9 days after immunization, with peak incidence by day 12. Demyelination occurred 1-2 days after inflammation began. Loss of RGC axons was detected following demyelination, with significant axonal loss occurring by day 13 post-immunization. Axonal loss occurred prior to loss of RGC bodies at day 14. Apoptotic cells were also observed at day 14 in the ganglion cell layer of eyes with optic neuritis, but not in control eyes. Together these results suggest that inflammatory cell infiltration mediates demyelination and leads to direct axonal injury in this model of experimental optic neuritis. RGCs die by an apoptotic mechanism triggered by axonal injury. Potential neuroprotective therapies to prevent permanent RGC loss from optic neuritis will likely need to be initiated prior to axonal injury to preserve neuronal function.

Entities:  

Mesh:

Year:  2008        PMID: 18653182      PMCID: PMC2564281          DOI: 10.1016/j.exer.2008.05.017

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  31 in total

Review 1.  Multiple sclerosis.

Authors:  J H Noseworthy; C Lucchinetti; M Rodriguez; B G Weinshenker
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

2.  Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

Authors:  Jerome R Wujek; Carl Bjartmar; Edward Richer; Richard M Ransohoff; Min Yu; Vincent K Tuohy; Bruce D Trapp
Journal:  J Neuropathol Exp Neurol       Date:  2002-01       Impact factor: 3.685

3.  IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.

Authors:  Bruno Gran; Guang-Xian Zhang; Shuo Yu; Jifen Li; Xiao-Han Chen; Elvira S Ventura; Malek Kamoun; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

4.  Acute neuronal apoptosis in a rat model of multiple sclerosis.

Authors:  R Meyer; R Weissert; R Diem; M K Storch; K L de Graaf; B Kramer; M Bahr
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

5.  Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse.

Authors:  Hui Shao; Zhigang Huang; Sheher L Sun; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-11       Impact factor: 4.799

6.  Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.

Authors:  A Parry; R Corkill; A M Blamire; J Palace; S Narayanan; D Arnold; P Styles; P M Matthews
Journal:  J Neurol       Date:  2003-02       Impact factor: 4.849

7.  Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.

Authors:  Muriel Hobom; Maria K Storch; Robert Weissert; Katharina Maier; Anand Radhakrishnan; Birgit Kramer; Mathias Bähr; Ricarda Diem
Journal:  Brain Pathol       Date:  2004-04       Impact factor: 6.508

8.  Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis.

Authors:  M B Sättler; D Merkler; K Maier; C Stadelmann; H Ehrenreich; M Bähr; R Diem
Journal:  Cell Death Differ       Date:  2004-12       Impact factor: 15.828

9.  SIRT1 activation confers neuroprotection in experimental optic neuritis.

Authors:  Kenneth S Shindler; Elvira Ventura; Tonia S Rex; Peter Elliott; Abdolmohamad Rostami
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

10.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  69 in total

1.  Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.

Authors:  Grazyna Adamus; Lori Brown; Shayne Andrew; Roberto Meza-Romero; Gregory G Burrows; Arthur A Vandenbark
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

2.  In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques.

Authors:  Michaela A Seigo; Elias S Sotirchos; Scott Newsome; Aleksandra Babiarz; Christopher Eckstein; E'tona Ford; Jonathan D Oakley; Stephanie B Syc; Teresa C Frohman; John N Ratchford; Laura J Balcer; Elliot M Frohman; Peter A Calabresi; Shiv Saidha
Journal:  J Neurol       Date:  2012-03-15       Impact factor: 4.849

3.  Anatomical and functional retinal changes in multiple sclerosis.

Authors:  G Cennamo; M R Romano; E C Vecchio; C Minervino; C Della Guardia; N Velotti; A Carotenuto; S Montella; G Orefice; G Cennamo
Journal:  Eye (Lond)       Date:  2015-12-18       Impact factor: 3.775

4.  Roles of Treg/Th17 Cell Imbalance and Neuronal Damage in the Visual Dysfunction Observed in Experimental Autoimmune Optic Neuritis Chronologically.

Authors:  Yuanyuan Liu; Caiyun You; Zhuhong Zhang; Jingkai Zhang; Hua Yan
Journal:  Neuromolecular Med       Date:  2015-08-30       Impact factor: 3.843

5.  Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis.

Authors:  Oliver W Gramlich; Stephanie C Joachim; Philip F Gottschling; Panagoitis Laspas; Clemens S Cuny; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-02-23       Impact factor: 3.117

6.  Macular changes of neuromyelitis optica through spectral-domain optical coherence tomography.

Authors:  Lu Cheng; Jing Wang; Xu He; Xun Xu; Zhen-Fen Ling
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

7.  Macular Ganglion Cell and Inner Plexiform Layer Thickness Is More Strongly Associated With Visual Function in Multiple Sclerosis Than Bruch Membrane Opening-Minimum Rim Width or Peripapillary Retinal Nerve Fiber Layer Thicknesses.

Authors:  James Nguyen; Alissa Rothman; Natalia Gonzalez; Ama Avornu; Esther Ogbuokiri; Laura J Balcer; Steven L Galetta; Elliot M Frohman; Teresa Frohman; Ciprian Crainiceanu; Peter A Calabresi; Shiv Saidha
Journal:  J Neuroophthalmol       Date:  2019-12       Impact factor: 3.042

8.  Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis.

Authors:  Tsen-Hsuan Lin; William M Spees; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neurobiol Dis       Date:  2014-03-13       Impact factor: 5.996

9.  Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity.

Authors:  Yong Chen; Reas S Khan; Alyssa Cwanger; Ying Song; Catherine Steenstra; Sookhee Bang; Jaime H Cheah; Joshua Dunaief; Kenneth S Shindler; Solomon H Snyder; Sangwon F Kim
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

10.  A mechanism of virus-induced demyelination.

Authors:  Jayasri Das Sarma
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.